SGS and RAPS Boston Chapter Symposium: 2026 Supply Chain Risks

Join SGS for the 2026 Risks with Pharmaceutical and Medical Devices in the Supply Chain Symposium

SGS is partnering with the RAPS Boston Chapter for the 2026 Risks with Pharmaceutical and Medical Devices in the Supply Chain symposium on August 13, 2026, at Babson College in Babson Park, Massachusetts. The one-day program will bring together regulatory, quality, compliance, and supply chain professionals to examine current risks affecting pharmaceutical and medical device supply chains.

SGS experts will lead discussions throughout the day, covering pharmaceutical storage and distribution, combination products, audit risks, extractables and leachables, validation, digital trust, and supply chain risk. Attendees will also have opportunities to explore these topics through panel discussions and connect during the closing reception.

Explore Key Regulatory and Supply Chain Topics

• Pharmaceutical Quality and Distribution: Explore APIs, finished pharmaceuticals, storage and distribution, along with EXCiPACT GMP, GDP, and PAMs.
• Combination Products: Examine regulatory considerations and practical approaches to managing supply chain risks for combination products.
• Extractables and Leachables: Hear an update on considerations affecting product quality and compliance.
• Audits and Validation: Examine common audit risks and non-conformances, along with validation-driven approaches to quality, compliance, and efficiency.
• Digital Trust: Explore cybersecurity, data, and AI governance considerations affecting regulated organizations.
• Supply Chain Risk: Discuss risks and solutions relevant to pharmaceutical and medical device supply chains.

Meet the SGS Experts

The program features SGS specialists across pharmaceutical, medical device, laboratory, and digital trust disciplines:

• John Gawlak, Technical Manager / Senior Auditor, SGS: Presenting on pharmaceutical storage and distribution, EXCiPACT GMP and GDP, audit risks and non-conformances, validation-driven quality, and supply chain risks and solutions.
• Mingxiang Xu, Technical Director, Product Assessor Medical Devices, SGS North America: Presenting on combination product regulatory strategy and practical supply chain risks.
• Dr. Dujuan Lu, Head of Extractables and Leachables, SGS: Providing an update on extractables and leachables.
• Gonda Lamberink, VP of Digital Trust, SGS: Discussing the cyber, data, and AI governance journey.

Supporting Medical Device Compliance

At SGS, we help bring medical devices to market safely and efficiently. As a full-solution provider, we help medical device clients ensure their products are of highest and consistent quality, while meeting the regulatory requirements for their intended purpose. We offer medical device CE marking as a Notified Body through our affiliate in Belgium (1639) for clients needing certification specifically for Software as a Medical Device (SaMD) products. SGS is a UK Approved Body (0120) able to provide conformity assessments under the UKCA scheme for Great Britain and is an Auditing Organization (AO) for MDSAP certification. SGS provides training, assessment, testing and certification through our network of more than 2,700 offices and laboratories across the world.

Join SGS and the RAPS Boston Chapter for a day of practical discussion focused on strengthening compliance, managing risk, and building more resilient pharmaceutical and medical device supply chains.

For further information, please contact:

Dominic James
Marketing Assistant
t: +1-201-508-3000